Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Corvus Pharmaceuticals
CRVS
$459M
| $11.2K | ﹤0.01% |
+2,141
| New | +$11.2K |
|
|
SLN
1502
Silence Therapeutics
SLN
$265M
| $11.1K | ﹤0.01% |
+1,566
| New | +$11.1K |
|
1503
Virtu Financial
VIRT
$3.29B
| $11.1K | ﹤0.01% |
311
-63
| -17% | -$2.25K |
|
1504
Braskem
BAK
$1.4B
| $11.1K | ﹤0.01% |
2,912
-100
| -3% | -$380 |
|
|
SVC
1505
Service Properties Trust
SVC
$481M
| $11K | ﹤0.01% |
4,398
-2,036
| -32% | -$5.07K |
|
1506
Trevi Therapeutics
TRVI
$854M
| $10.9K | ﹤0.01% |
+2,561
| New | +$10.9K |
|
|
SLRN
1507
DELISTED
ACELYRIN
SLRN
| $10.9K | ﹤0.01% |
3,343
-267
| -7% | -$868 |
|
1508
Liberty Live Group Series C
LLYVK
$8.88B
| $10.8K | ﹤0.01% |
156
-94
| -38% | -$6.49K |
|
|
RVNC
1509
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10.7K | ﹤0.01% |
3,496
-295
| -8% | -$903 |
|
1510
Aquestive Therapeutics
AQST
$656M
| $10.7K | ﹤0.01% |
+3,038
| New | +$10.7K |
|
1511
Absci
ABSI
$368M
| $10.6K | ﹤0.01% |
+3,827
| New | +$10.6K |
|
|
HPP
1512
Hudson Pacific Properties
HPP
$1.17B
| $10.5K | ﹤0.01% |
3,547
-1,384
| -28% | -$4.11K |
|
1513
Voyager Therapeutics
VYGR
$235M
| $10.4K | ﹤0.01% |
1,820
-152
| -8% | -$872 |
|
|
CBL
1514
CBL Properties
CBL
$991M
| $10.2K | ﹤0.01% |
343
-152
| -31% | -$4.52K |
|
|
DHC
1515
Diversified Healthcare Trust
DHC
$997M
| $10.2K | ﹤0.01% |
4,699
-1,839
| -28% | -$3.99K |
|
|
LAND
1516
Gladstone Land Corp
LAND
$325M
| $10.1K | ﹤0.01% |
950
-371
| -28% | -$3.95K |
|
1517
Rigel Pharmaceuticals
RIGL
$741M
| $9.69K | ﹤0.01% |
+587
| New | +$9.69K |
|
1518
Zillow
ZG
$20.5B
| $9.67K | ﹤0.01% |
133
-80
| -38% | -$5.82K |
|
1519
Atea Pharmaceuticals
AVIR
$267M
| $9.37K | ﹤0.01% |
2,815
-238
| -8% | -$793 |
|
1520
Vanda Pharmaceuticals
VNDA
$272M
| $9.35K | ﹤0.01% |
1,943
-165
| -8% | -$794 |
|
1521
Lexicon Pharmaceuticals
LXRX
$400M
| $9.32K | ﹤0.01% |
12,046
-1,028
| -8% | -$795 |
|
1522
Gaotu Techedu
GOTU
$877M
| $9.16K | ﹤0.01% |
4,241
-135
| -3% | -$292 |
|
1523
Lemonade
LMND
$3.71B
| $9.02K | ﹤0.01% |
246
-39
| -14% | -$1.43K |
|
1524
AC Immune
ACIU
$230M
| $9K | ﹤0.01% |
3,296
-281
| -8% | -$767 |
|
1525
Foghorn Therapeutics
FHTX
$326M
| $8.93K | ﹤0.01% |
+1,853
| New | +$8.93K |
|